ARTICLES 22 Patolsky, F. et al. Electrical detection of single viruses. Proc. Natl. Acad. Sci. USA 101, 36. Kim, N w. et al. specife association of human telomerase activity with immortal cells 23. Wang, W.U., Chen, C, Lin, K.H., Fang, Y. Lieber, C M. Label-free detection of small- 37. Nugent, C 1.& Lundbl reverse transcriptase: components ctions by using nanowire nanosensors. Proc. Natl. Acad. Sci. regulation. Genes Dev. 12, 1073-1085(1998). 24 Armbruster, D.A. Prostate-specific antigen: biochemistry, analytical methods and 38902565290 39. Hirose, M. et al. A rapid, useful and quantitative method to measure telomerase activity 25 Pomerantz, M, Segmuller, A, Netzer, L.& Sagiv, J. Coverage of si substrates by self by hybridization pro ssembling monolayers and multilayers as measured by IR, wettability and x-ray 123,337-344(1997 Solid Films 13 40 Gelmini. S. ef al 26. Heiney, P.A., Gruneberg, K, Fi cey, C. & Shashidhar, R. Structure and human tumors. Clin Chem. 44 38(1998).y for telomerase activity in owth of chromophore-functionalized (3-aminopropyl )triethoxysilane self-assembled 41. Uehara, H, Nardone, G, Nazarenko, l. Hohman, R.J. Detection of telomerase activity 1-2657(2000 ques 26, 552-558 S: comparison with gel-and ELISA-based detection edominantly in with 42. Szatmar C B, Bardos, T.&Aradi, J. Modified telomeric repeat -antichymotrypsin clin Chem. 37, 1618-1625(1991) .trypsin is the major form of post te-specific antigen in serum ot patients t wiah tichet assay for telomerase with 32,80-88 tatic 43 Wege, H, Chui, M.S., Le, H T, Tran, J M. 0M SYBR Green re assay of the complex improves clinical sensitivity for cancer. Cancer Res 51. Ae the rapid quantification of telomerase activity. Nucleic ds Res.31(No.2e3),1-7(2003) ef al. The proportion of prostate-specific antigen(PSA) complexed to 44 Mitsuya, H, Yarchoan, R. Broder, s Molecular targets for AIDS therapy. Science of 10 to 30 ug/L. Clin Chem. 48, 1251- 45. Miyashita, M, Shimada, T, miyagawa, H. Akamatsu, M. Surface plasmon esonance-based immunoassay for 17 beta-estradiol and its application to the me the telomeres of human-chromosomes. Proc. Natl. Acad. Sci. USA 85. 6622-6626 surement of estrogen receptor binding activity. Anal. Bioanal. Chem. 381, 667-673 2005) 46 Haes, A., Hall, W.P., Chang, L, Klein, W.L.& van duyne, R. P. A localized surface 3 32. Morin, G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein plasmon resonance biosensor: first steps toward an assay for Alzheimers disease. Nano i that synthesizes TTAGGG repeats. Cell 59. 521-529(1989) 33. 0'Reilly, M, Teichmann, s.A.& Rhodes, D. Telomerases. Curr. Opin. Struct. Biol. 9, 47. Cui, Y, Zhong. Z, Wang, D, Wang, W.U.& Lieber C M. High performance silicon 34. Rhyu, M.S. Telomeres, telomerase and immortality. J. Natl. Cancer Inst. 87, 884-894 48. Zheng, G, Lu, W, Jin, S.& Lieber, C M. Synthesis and fabrication of high-performance 9 35. Shay, J.w.& Bacchetti, S. A survey of telomerase activity in human cancer. Eur J. 49. Wong, P K, Chen, C Y, Wang. T.H. Ho, C.M. Elec processor for concentrating cells and molecules. Anal. Chem. 76, 6908-6914(2004 ATURE BIOTECHNOLOGY VOLUME 23 NUMBER 10 OCTOBER 2005 130122. Patolsky, F. et al. Electrical detection of single viruses. Proc. Natl. Acad. Sci. USA 101, 14017–14022 (2004). 23. Wang, W.U., Chen, C., Lin, K.H., Fang, Y. & Lieber, C.M. Label-free detection of small￾molecule–protein interactions by using nanowire nanosensors. Proc. Natl. Acad. Sci. USA 102, 3208–3212 (2005). 24. Armbruster, D.A. Prostate-specific antigen: biochemistry, analytical methods and clinical application. Clin. Chem. 39, 181–195 (1993). 25. Pomerantz, M., Segmuller, A., Netzer, L. & Sagiv, J. Coverage of Si substrates by self￾assembling monolayers and multilayers as measured by IR, wettability and x-ray diffraction. Thin Solid Films 132, 153–162 (1985). 26. Heiney, P.A., Gruneberg, K., Fang, J.Y., Dulcey, C. & Shashidhar, R. Structure and growth of chromophore-functionalized (3-aminopropyl)triethoxysilane self-assembled on silicon. Langmuir 16, 2651–2657 (2000). 27. Sze, S.M. Physics of Semicondutor Devices (John Wiley & Sons, New York, 1981). 28. Lilja, H. et al. Prostate-specific antigen in serum occurs predominantly in complex with a1-antichymotrypsin. Clin. Chem. 37, 1618–1625 (1991). 29. Stenman, U.H. et al. A complex between prostate-specific antigen and a1-antichymo￾trypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51, 222–226 (1991). 30. Martinez, M. et al. The proportion of prostate-specific antigen (PSA) complexed to a1-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 mg/L. Clin. Chem. 48, 1251– 1256 (2002). 31. Moyzis, R.K. et al. A highly conserved repetitive DNA-sequence, (TTAGGG)N, present at the telomeres of human-chromosomes. Proc. Natl. Acad. Sci. USA 85, 6622–6626 (1988). 32. Morin, G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521–529 (1989). 33. O’Reilly, M., Teichmann, S.A. & Rhodes, D. Telomerases. Curr. Opin. Struct. Biol. 9, 56–65 (1999). 34. Rhyu, M.S. Telomeres, telomerase and immortality. J. Natl. Cancer Inst. 87, 884–894 (1995). 35. Shay, J.W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787–791 (1997). 36. Kim, N.W. et al. Specifc association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994). 37. Nugent, C.I. & Lundblad, V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12, 1073–1085 (1998). 38. Shippen-Lentz, D. & Blackburn, E.H. Functional evidence for an RNA template in telomerase. Science 247, 546–552 (1990). 39. Hirose, M. et al. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J. Cancer Res. Clin. Oncol. 123, 337–344 (1997). 40. Gelmini, S. et al. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clin. Chem. 44, 2133–2138 (1998). 41. Uehara, H., Nardone, G., Nazarenko, I. & Hohman, R.J. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection. Biotechniques 26, 552–558 (1999). 42. Szatmari, I., Tokes, S., Dunn, C.B., Bardos, T.J. & Aradi, J. Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis. Anal. Biochem. 282, 80–88 (2000). 43. Wege, H., Chui, M.S., Le, H.T., Tran, J.M. & Zern, M.A. SYBR Green real time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res. 31 (No. 2 e3), 1–7 (2003). 44. Mitsuya, H., Yarchoan, R. & Broder, S. Molecular targets for AIDS therapy. Science 249, 1533–1544 (1990). 45. Miyashita, M., Shimada, T., Miyagawa, H. & Akamatsu, M. Surface plasmon resonance-based immunoassay for 17 beta-estradiol and its application to the mea￾surement of estrogen receptor-binding activity. Anal. Bioanal. Chem. 381, 667–673 (2005). 46. Haes, A.J., Hall, W.P., Chang, L., Klein, W.L. & Van Duyne, R.P. A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer’s disease. Nano Lett. 4, 1029–1034 (2004). 47. Cui, Y., Zhong, Z., Wang, D., Wang, W.U. & Lieber, C.M. High performance silicon nanowire field effect transistors. Nano Lett. 3, 149–152 (2003). 48. Zheng, G., Lu, W., Jin, S. & Lieber, C.M. Synthesis and fabrication of high-performance n-type silicon nanowire transistors. Adv. Mater. 16, 1890–1893 (2004). 49. Wong, P.K., Chen, C.-Y., Wang, T.-H. & Ho, C.-M. Electrokinetic bioprocessor for concentrating cells and molecules. Anal. Chem. 76, 6908–6914 (2004). NATURE BIOTECHNOLOGY VOLUME 23 NUMBER 10 OCTOBER 2005 1301 ARTICLES © 2005 Nature Publishing Group http://www.nature.com/naturebiotechnology